Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 207,800 shares at $19.28 ($4.2M) on 2023-07-19, disclosed to the SEC on 2023-07-21.
Scheduled sale ($4.2M) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.28 | 4,174 | $80K | 1.9% |
| 2 | $19.28 | 4,174 | $80K | 1.9% |
| 3 | $20.04 | 99,726 | $2.0M | 48.1% |
| 4 | $20.04 | 99,726 | $2.0M | 48.1% |
| Total | $20.01 avg | 207,800 | $4.2M | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |